GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Precision BioSciences Inc (FRA:PBS0) » Definitions » Additional Paid-In Capital

Precision BioSciences (FRA:PBS0) Additional Paid-In Capital : €477.66 Mil(As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Precision BioSciences Additional Paid-In Capital?


Precision BioSciences's quarterly additional paid-in capital declined from Sep. 2023 (€471.65 Mil) to Dec. 2023 (€467.16 Mil) but then increased from Dec. 2023 (€467.16 Mil) to Mar. 2024 (€477.66 Mil).

Precision BioSciences's annual additional paid-in capital increased from Dec. 2021 (€361.78 Mil) to Dec. 2022 (€462.27 Mil) and increased from Dec. 2022 (€462.27 Mil) to Dec. 2023 (€467.16 Mil).


Precision BioSciences Additional Paid-In Capital Historical Data

The historical data trend for Precision BioSciences's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Precision BioSciences Additional Paid-In Capital Chart

Precision BioSciences Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial 284.70 272.45 361.78 462.27 467.16

Precision BioSciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 461.86 461.74 471.65 467.16 477.66

Precision BioSciences Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Precision BioSciences Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Precision BioSciences's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Precision BioSciences (FRA:PBS0) Business Description

Traded in Other Exchanges
Address
302 East Pettigrew Street, Dibrell Building, Suite A-100, Durham, NC, USA, 27701
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.

Precision BioSciences (FRA:PBS0) Headlines

No Headlines